Neurogene Inc.
NGNE
$29.82
-$1.45-4.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.97% | -20.24% | -59.88% | -77.27% | -97.36% |
| Total Depreciation and Amortization | 0.00% | -4.77% | -5.31% | -4.97% | -3.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.43% | 35.33% | 181.18% | 170.39% | 162.95% |
| Change in Net Operating Assets | 556.07% | 104.50% | 57.31% | 98.56% | 92.37% |
| Cash from Operations | -18.34% | -9.31% | -10.22% | -10.92% | -17.15% |
| Capital Expenditure | 55.09% | -46.41% | -42.80% | -64.76% | -326.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 153.33% | 112.20% | -590.44% | -1,517.91% | -667.77% |
| Cash from Investing | 152.58% | 111.18% | -3,811.81% | -627.54% | -460.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 7.14% | -17.31% | -17.02% | -20.00% | -60.00% |
| Issuance of Common Stock | -83.79% | -83.93% | 16,739.56% | 17,521.11% | 27,732.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 96.63% | -100.19% | -100.00% | -100.00% |
| Cash from Financing | -83.94% | -83.47% | 126.30% | 120.36% | 122.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.27% | -177.63% | -79.58% | -199.80% | -196.87% |